miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2

E-ISSN： 1875-5992|14|6|884-891

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.14, Iss.6, 2014-07, pp. : 884-891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1

By Zhou Li Qiu Tianzhu Xu Jing Wang Tongshan Wang Jian Zhou Xin Huang Zebo Zhu Wei Shu Yongqian Liu Ping

Pathology & Oncology Research, Vol. 19, Iss. 4, 2013-10 ,pp. : 677-683

Springer Publishing Company

Access to resources Recommend Favorite

miR210 regulates esophageal cancer cell proliferation by inducing G2/M phase cell cycle arrest through targeting PLK1

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 2099-2104

Spandidos Publications

Access to resources Recommend Favorite

miR-506 regulates breast cancer cell metastasis by targeting IQGAP1

International Journal of Oncology, Vol. 47, Iss. 5, 2015-01 ,pp. : 1963-1970

Spandidos Publications

Access to resources Recommend Favorite

MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer

Oncology Reports, Vol. 27, Iss. 2, 2012-01 ,pp. : 594-598

Spandidos Publications

Access to resources Recommend Favorite

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 967-971

Spandidos Publications

Access to resources Recommend Favorite